By: Arlene Weintraub From: forbes.com An impressive 45 novel drugs have been approved by the FDA in 2017 so far — more than doubling last year’s total. A dozen of those new products were in oncology, as the year ushered in new choices for treating a range of cancers, including mantle cell lymphoma, Merkel cell carcinoma and follicular lymphoma. But what’s …